Carmell Therapeutics' Series A - II Round

Carmell Therapeutics raised a round of funding on February 02, 2014.

Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …

Articles about Carmell Therapeutics' Series A - II Round: